BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30042279)

  • 1. [A Case of Recurrent Breast Cancer with Complete Response to Eribulin Monotherapy after Bevacizumab plus Paclitaxel Combination Therapy].
    Higashi T; Ozawa K; Takagi S; Onodera Y; Yokoyama M; Mase K; Moriya T; Takeshita A; Mizutani M; Usuba O
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1093-1095. PubMed ID: 30042279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case report.
    Ishizuna K; Ninomiya J; Kojima M; Kawashima M; Nozaki M; Yamagishi H; Ueda Y; Oya M
    BMC Res Notes; 2013 Jul; 6():254. PubMed ID: 23830415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators.
    Inoue K; Ninomiya J; Saito T; Kimizuka K; Kurosumi M
    BMC Cancer; 2018 Jun; 18(1):671. PubMed ID: 29925345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term response to eribulin in patients with metastatic breast cancer-report of 2 cases].
    Hara Y; Sakurai K; Nagashima S; Suzuki S; Waga E; Matsumoto K; Hagiwara M; Maeda T; Hirano T; Enomoto K; Tani M; Amano S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2372-4. PubMed ID: 24394116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Biweekly Paclitaxel and Bevacizumab].
    Yoshida T; Goto Y; Sakiyama K; Kimura M
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1397-1400. PubMed ID: 27899783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maintenance of Long-Term Stable Disease(SD)in Metastatic Breast Cancer with Eribulin - A Case Report of Long-Term SD in Japan].
    Nitta T; Kimura K; Tominaga T; Fujii K; Sato N; Ikari A; Miyoshi K; Tanaka S; Ishibashi T; Iwamoto M
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2543-2546. PubMed ID: 28028262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two Cases in Which Eribulin Mesylate Was Effective for Taxane-Resistant Advanced Breast Cancer].
    Adachi K; Suzuki S; Kubota H; Hara Y; Fujiwara A; Waga E; Hirano T; Enomoto K; Sakurai K; Makishima M; Koshinaga T
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):938-940. PubMed ID: 29066702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab.
    Ueda S; Saeki T; Takeuchi H; Shigekawa T; Yamane T; Kuji I; Osaki A
    Br J Cancer; 2016 May; 114(11):1212-8. PubMed ID: 27140309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
    Watanabe N; Furukawa J; Minoji T; Tamai K; Kitahara T; Yamamura N; Okamura S; Fukuchi N; Ebisui C; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1097-1099. PubMed ID: 30042280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Axillary Arterial Bleeding with Administration of Bevacizumab plus Paclitaxel in a Patient with Recurrent Breast Cancer-A Case Report].
    Tsuruda Y; Masuda T; Hayashi N; Noda M; Otsu H; Kuroda Y; Eguchi H; Tanaka F; Natsugoe S; Mimori K
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):117-119. PubMed ID: 32381877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine Monotherapy after Failure of Combination Therapy Comprising Bevacizumab and Paclitaxel].
    Ooe A; Suganuma Y
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):349-51. PubMed ID: 27067853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged remission achieved by using bevacizumab plus paclitaxel therapy combined with sequential radiotherapy for a rapidly growing chest wall recurrence of triple negative breast cancer - a case report].
    Kawashima M; Fujii K; Kiso M; Takeyama O; Kan S; Tanaka M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):81-4. PubMed ID: 25596684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
    Tsubota Y; Sueoka N; Yamamoto D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Paclitaxel and Bevacizumab after Radical Mastectomy].
    Sakaguchi N; Moriya T; Yamazaki T; Yamagishi Y; Hasegawa S; Tsuda H; Hase K; Yamamoto J
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):751-3. PubMed ID: 26199251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent breast cancer with carcinomatous pleurisy responding to bevacizumab and paclitaxel therapy].
    Sato Y; Nakagawa T; Sato T; Nagahara M; Sugihara K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2387-9. PubMed ID: 24394121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab].
    Kawai H; Sugimoto R; Miyauchi S; Yoshida R; Waki N; Hirayama S; Ishizaki M; Nishi H; Yamashita K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
    Yardley DA; Reeves J; Dees EC; Osborne C; Paul D; Ademuyiwa F; Soliman H; Guthrie T; Andersen J; Krekow L; Choksi J; Daniel B; Danso M; Favret A; Oommen S; Brufsky A; Bromund JL; Lin Y; Ibrahim AB; Richards PD
    Clin Breast Cancer; 2016 Dec; 16(6):471-479.e1. PubMed ID: 27569274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
    Dottorini L; Catena L; Sarno I; Di Menna G; Marte A; Bajetta E
    Oncology; 2018; 94 Suppl 1(Suppl 1):6-9. PubMed ID: 30036862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.